MedPath

Role of Pippali churna in Dyslipidemia

Phase 2
Conditions
Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified
Registration Number
CTRI/2024/07/071746
Lead Sponsor
G J Patel Institute of Ayurvedic Studies and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Subjects willing to give written consent and anticipated ability to attend the scheduled visits.

•Subjects those who have cholesterol levels at risk (Borderline High) selected for the study.

Total Cholesterol: 200-239mg/dl,

LDL Cholesterol: 100-159mg/dl,

HDL Cholesterol: 40-59mg/dl male ,50-59mg/dl female

Triglycerides : 150-199mg/dl

Exclusion Criteria

? Subjects those who have cholesterol levels at Dangerous not selected for the study.

Total Cholesterol 240mg/dl and Higher ,LDL Cholesterol 160 mg/dl Higher HDL Cholesterol lees than40 mg/dl males,

Less than 50mg/dl female Triglyceride-200 mg/ dl and Higher

Subjects with any other acute or chronic systemic illness or infection.

Dyslipidemia associated with Obesity or Diabetes.

Pitta predominant Prakruti subjects.

Pregnant and Lactating women.

Subjects taking anti-cholesterol drugs(Both Ayurvedic and modern drugs)

Known cases of Acid Peptic Disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome: Pippali churna can make positive impact on Dyslipidemia. <br/ ><br> <br/ ><br>Timepoint: 90 DAYS <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Pippali Churna can make positive impact on weight & BMI of the participantsTimepoint: 90 DAYS
© Copyright 2025. All Rights Reserved by MedPath